Lycera Corporation

Selective, small-molecule immunomodulators for autoimmune diseases.

Lycera is a biopharmaceutical company that seeks to uncover new small molecule therapies for the treatment of autoimmune diseases and cancer.

Partnerships

 

  

  

 

  

  

 

  

  

Clients